Nanoform Q1 2026 report – Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology
Nanoform Finland Plc | Company Release | May 19, 2026…
Inside information: Nanoform Signs First Exclusivity Agreement for Ultra-High Concentration Subcutaneous Delivery
Nanoform Finland Plc | Inside Information | May 12, 2026…
Invitation to Nanoform’s Q1 2026 Report Presentation
Nanoform Finland Plc | Press Release | May 05, 2026…
Resolutions of Nanoform Finland Plc’s Annual General Meeting on April 21, 2026
Nanoform Finland Plc | Company Release | April 21, 2026…
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Nanoform Finland Plc | Company Release | April 21, 2026…
Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Nanoform Finland Plc | Company Release | April 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen
Nanoform Finland Plc | Company Release | April 02, 2026…
Inside information: Feedback from European Scientific Advice Meeting with Reference Member State Will Delay Submission of European Marketing Authorization Application Planned Initially for May 2026
Nanoform Finland Plc | Inside Information | March 30, 2026…
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen
Nanoform Finland Oyj:n (”Yhtiö”) (Y-tunnus: 2730572-8) osakkeenomistajat kutsutaan varsinaiseen yhtiökokoukseen,…
Notice to the Annual General Meeting of NANOFORM FINLAND Plc
Nanoform Finland Plc | Company Release | March 19, 2026…
Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Antonio Da Silva
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – David Rowe
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Edward Hæggström
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Christian Jones
Nanoform Finland Plc | Company Release | March 02, 2026…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Q4 & FY2025 report – Next: the submission of a marketing authorization application for Nanoenzalutamide in Europe
Nanoform Finland Plc | Company Release | February 26, 2026…
Invitation to Nanoform’s Q4 and FY2025 Report Presentation
Nanoform Finland Plc | Press Release | February 13, 2026…
Nanoform – Subcutaneously administered Nanotrastuzumab matches performance of Herceptin HYLECTA in minipig study
Nanoform Finland Plc | Press Release | February 12, 2026…
Nanoform Finland Plc’s change negotiations have ended
Nanoform Finland Plc | Company Release | February 05, 2026…
Nanoform – Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act
Nanoform Finland Plc | Company Release | January 29, 2026…
Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030
Nanoform Finland Plc | Inside Information | January 07, 2026…